loader2
Login Open ICICI 3-in-1 Account
Text Size
Text to Speech
Color Contrast
Pause Animations
Open ICICI 3-in-1 Account

BSE MidCap Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
GMR Airports Ltd. 16 Feb 2026 12:06 PM
Result PDF

Q3FY26 Quarterly Result Announced for GMR Airports Ltd.

Construction & Engineering company GMR Airports announced Q3FY26 results

  • Total Income: Rs 4,083 crore against Rs 2,748 crore during Q3FY25, change 49%.
  • EBITDA: Rs 1,789 crore against Rs 1,087 crore during Q3FY25, change 65%.
  • PBT: Rs 408 crore against Rs -221 crore during Q3FY25, change 285%.
  • PAT: Rs 174 crore against Rs 202 crore during Q3FY25, change -14%.

Result PDF

Result PDF

Internet & Catalogue Retail company Brainbees Solutions announced Q3FY26 results

  • Revenue from operations: Rs 24,236.31 million against Rs 21,723.09 million during Q3FY25, change 12%.
  • PBT: Rs -51.94 million against Rs 68.83 million during Q3FY25.
  • PAT: Rs -384.04 million against Rs -147.38 million during Q3FY25.
  • EPS: Rs -0.59 for Q3FY26.

Result PDF

Financial Services company Crisil announced Q4CY25 results

  • Consolidated income from operations for Q4CY25 was up 18.5% to Rs 1,081.6 crore, compared with Rs 912.9 crore in Q4CY24.
  • Consolidated total income for Q4CY25, rose 17.5% to Rs 1,108.7 crore, compared with Rs 943.2 crore in Q4CY24.
  • Profit before tax for Q4CY25 was up 10.9% to Rs 326.5 crore, compared with Rs 294.5 crore in Q4CY24.
  • Profit after tax was up 7 .5% to Rs 241.5 crore, compared with Rs 224.7 crore in Q4CY24.
  • The Board of Directors has recommended a final dividend of Rs 28 per share (of Re 1 face value), taking the total dividend for the year to Rs 61 per share.

Says Amish Mehta, Managing Director & CEO, Crisil, said: "We saw strong revenue and EBITA growth compared with last year, driven by consistent financial delivery and operational resilience across our businesses. While a dynamic macroeconomic backdrop persists, we are committed to delivering sustainable growth through continuous investments in creating new products and solutions, expanding our client footprint, and developing future-ready talent. We focus on creating domain-led GenAI solutions that drive competitiveness by enhancing client experiences and insights and augmenting operational efficiencies. Notably, Crisil is marching towards its 40th year of making markets function better, driven by deep institutional intelligence and rich experience honed by economic cycles, reforms and shocks, and as a steadfast ally in the Viksit Bharat quest."

Result PDF

2/3 Wheelers company Ola Electric Mobility announced Q3FY26 results

  • The company’s consolidated revenue from operations stood at Rs 470 crore, with total E2W deliveries of 32,680 units in Q3FY26.
  • Consolidated Gross Margin at 34.3%, up 15.7 pp YoY and 3.4 pp QoQ - highest in the electric two-wheeler industry.
  • Quarter marks structural operating model reset; quarterly opex reduced from Rs 840 crore peak (Q4FY25) to Rs 484 crore in Q3FY26 with roadmap of quarterly opex of Rs 250-300 crore over the next couple of quarters.
  • EBITDA breakeven reset to approximately 15,000 units monthly; current manufacturing footprint supports 3-4x volume scaling with minimal incremental fixed cost.
  • Nearly 80% same-day service completion; service backlog reduced approximately 50% from its peak.
  • Gigafactory doubles cell production QoQ; first commercial deployment of in-house 4680 Bharat Cells into customer vehicles.

Management commentary: “Q3FY26 marks a structural reset for Ola Electric. We chose to fix the fundamentals by restoring service execution, resetting our cost structure, and deepening vertical integration. The result is a leaner operating model with materially lower breakeven and industry-leading gross margins. With service metrics stabilising and our Gigafactory transitioning into commercial scale deployment, we are positioned to enter the next phase of growth with significantly improved operating leverage.”

Result PDF

Pharmaceuticals company Alkem Laboratories announced Q3FY26 results

  • Total Revenue from Operations was Rs 37,368 million, with YoY growth of 10.7%.
    • India sales were Rs 24,959 million, YoY growth of 5.5%.
    • International sales were Rs 12,157 million, with YoY growth of 26.6%.
  • Earnings before Interest, Tax, Depreciation, and Amortisation (EBITDA) were Rs 8,280 million, resulting in an EBITDA margin of 22.2% vs 22.5% in Q3FY25. EBITDA grew by 9.0% YoY.
  • R&D expenses for Q3FY26 were Rs 1,390 million, or 3.7% of total revenue from operations, vs Rs 1,312 million in Q3FY25 at 3.9% of total revenue from operations.
  • Profit before tax (after exceptional item) was Rs 7,812 million, YoY growth of 6.9%.
  • Net Profit (after Non-Controlling interest) was Rs 6,360 million, YoY growth of 1.6%.
  • Exceptional item for the quarter includes the impact of Rs 528 million on a preliminary basis related to the notification by the Government of India regarding the four Labour Codes.
  • According to IQVIA (SSA) data, for Q3FY26:
    • The Company registered a growth of 9.8% YoY vs the Indian Pharmaceutical Market (IPM), which grew by 10.9%.
    • Acute segment reported growth of 8.6% vs IPM, which grew by 7.8%, 80 bps outperformance.
    • Chronic segment reported growth of 15.8% vs IP,M which grew by 15.6%, 18 bps outperformance.

Sandeep Singh, Managing Director, Alkem Laboratories, said: “This acquisition holds strategic importance as we work towards establishing a global footprint in medical devices. Occlutech is the third-largest player globally in the minimally invasive cardiac implants segment. With its significant presence in high-barrier markets, best-in-class R&D and manufacturing, and robust quality systems, Occlutech provides a strong lever for Alkem MedTech to expand into cardiovascular, along with orthopaedics. Medtech is a natural extension for Alkem. In the company years, along with Enzene Biosciences, our Biotech arm, we expect Alkem MedTech to become a meaningful growth pillar for the company.”

Vikas Gupta, CEO, Alkem, said: “In Q3, we delivered a stable performance in a dynamic operating environment, supported by strong fundamentals in our domestic business and consistent execution across our international businesses. We remain bullish on the growth opportunities in domestic as well as international business and are on track to deliver our full-year guidance. Looking ahead, the planned launch of our GLP-1 semaglutide in March 2026 is expected to be among our key growth drivers. Our focus remains on execution, strengthening our product portfolio, and building long-term competitiveness across markets.”

Result PDF

Pharmaceuticals company Ipca Laboratories announced Q3FY26 results

Consolidated Financial Highlights:

  • Consolidated Net total Income up 7% at Rs 2,412.69 crore.
  • Consolidated EBITDA margin (before forex (gain)/loss, other income and exceptional items) @ 22.15% in Q3FY26 as against @ 19.87% in Q3FY25.
  • Consolidated Net Profit at Rs 326.27 crore (after exceptional items) up 31%.
  • Exports Income up 13% at Rs 770.49 crore.

Standalone Financial Highlights:

  • Standalone Net total Income up 11% at Rs 1,863.00 crore.
  • Standalone EBITDA margin (before forex (gain)/loss, other income and exceptional items) @ 26.09% in Q3FY26 as against @ 24.25% in Q3FY25.
  • Standalone Net Profit at Rs 303.45 crore (after exceptional items) up 13%.
  • Indian formulations income up 12% at Rs 984.00 crore.

Result PDF

Agrochemicals company PI Industries announced Q3FY26 results

  • Total Income: Rs 13,757 million against Rs 19,008 million during Q3FY25, change -28%.
  • EBITDA: Rs 3,027 million against Rs 5,122 million during Q3FY25, change -41%.
  • EBITDA Margin: 22% for Q3FY26.
  • PAT: Rs 3,113 million against Rs 3,727 million during Q3FY25, change -16%.
  • The company saw a ~32% decline in Agchem Exports (Volume down ~ 29 %) in line with the customer delivery schedule.
  • Pharma revenue contracted by 6% YoY due to the deferment of supply schedules to Q4FY26. Pharma revenue contributes ~5% of the export revenue.
  • Overheads increase, comprising the strategic development of new businesses and the promotion of new products (6%), offset by effective cost control in existing businesses.
  • The Board has approved an interim dividend for FY25-26 of Rs 5.00 per share.

Result PDF

Commodity Chemicals company Deepak Nitrite announced Q3FY26 results

  • Total Income: Rs 1,983 crore against Rs 1,924 crore during Q3FY25, change 3%.
  • EBITDA: Rs 219 crore against Rs 190 crore during Q3FY25, change 15%.
  • EBITDA Margin: 11% for Q3FY26.
  • PBT: Rs 138 crore against Rs 135 crore during Q3FY25, change 2%.
  • PAT: Rs 100 crore against Rs 98 crore during Q3FY25, change 2%.
  • PAT Margin: 5% for Q3FY26.
  • EPS: Rs 7.32 for Q3FY26.

Deepak C. Mehta, Chairman & Managing Director, said: “The chemical industry continues to experience significant pricing pressures driven by persistent oversupply and heightened competitive intensity, particularly from Chinese producers. Despite these external challenges, our diversified portfolio, operational discipline, and strong customer relationships hold us in good stead.

In Deepak Chem Tech Limited (DCTL), we have completed our vertical integration across the ammonia-nitration-amines chain establishing Deepak Group as a premier global player. This strategic move unlocks a wider product range, secures our operations against market volatility, and delivers superior margins and cost efficiency across our key intermediates.

In parallel, we have been taking decisive and tangible steps across the Phenol-to-Polycarbonate value chain, marking significant progress in our state of preparedness for this next phase of growth. We are systematically building an integrated ecosystem spanning through raw material security to final Polycarbonate product, supported by strategic tie-ups with key vendors and suppliers. Necessary financial arrangements and funding tie-ups have been put in place to underpin these initiatives, ensuring readiness from both - capital and balance-sheet perspective. Concurrently, engineering activities are underway, with technology sourcing and engagement with global licensors progressing as planned. Collectively, these actions represent a giant leap in our execution preparedness and reinforce our commitment to creating a fully integrated, high-value specialty materials platform.

During the third quarter, Deepak Group once again demonstrated resilience and adaptability in the face of a demanding global environment. Our core businesses remained operationally resilient during the quarter. The Phenolics segment benefited from consistent plant operations and improved volumes, reflecting the advantages of integration and our continued emphasis on efficiency. While pricing conditions across markets remained soft, the business sustained its momentum through prudent cost management and a balanced market approach. Our commitment to disciplined growth, operational excellence, and long-term value creation for stakeholders remains unwavering.

Recent developments in key export markets warrant cautious optimism, particularly for volume growth. In response, we remain firmly focused on innovation, new product development, and geographic diversification, across multiple chemistries.

While the Group continues to work on different value chains, it has committed to establish integration across chains. This increases overall margins, resilience in challenging times, also reduces carbon footprint. Deepak will continue to look at this across present and future investment plans. Three mantras would be our guiding principles creating different value chains with high degree of integration.

  • World’s best quality.
  • World’s best capacity.
  • Complete integration across value chain.

Current market condition of all petrochemical products globally are undergoing severe pressure, however, our integration would help us to be resilient and be ready to take benefits during cyclical turnarounds.”

Result PDF

Auto Parts & Equipment company Endurance Technologies announced Q3FY26 results

  • Total Income: Rs 3,646 crore against Rs 2,881 crore during Q3FY25, change 27%.
  • EBITDA: Rs 514 crore against Rs 394 crore during Q3FY25, change 30%.
  • EBITDA Margin: 14.1% for Q3FY26.
  • PBT: Rs 301 crore against Rs 247 crore during Q3FY25, change 22%.
  • PAT: Rs 222 crore against Rs 184 crore during Q3FY25, change 21%.
  • PAT Margin: 6.1% for Q3FY26.

Anurang Jain, Managing Director, said: "Two-wheeler sales volumes for Indian OEMs grew 18.2% YoY in Q3FY26; while passenger vehicle volumes recorded a 19.2% YoY growth. Endurance standalone Total Income grew ahead of market at 22.2%. Market growth was on account of improved affordability following the GST rationalisation, which continues to aid demand growth even after the festive season. An average end-user has become increasingly disce(ning, with preference for safer and more premium offerings. Consequently, OEMs are expanding feature content across both ICE and electric platforms.

We are well positioned to benefit from this shift through our strong presence in safety-critical categories such as disc brake systems and ABS, and in premium products such as Inverted Front Forks and Assist and Slip Clutches. Alongside our established leadership in two-wheelers, we are focused on expanding our presence in four-wheeler programmes and non-automotive applications, and a large part of our new orders won this year are for these applications.

In Europe, new car registrations during the quarter grew at 4.6% YoY, while our revenue growth in Euro terms was at 21%. The acquisition of Stoferle, which was consummated at the start of this financial year, has not only helped us to grow our business but also to diversify our customer base and strengthen our machining capabilities. Efforts are underway to identify more such inorganic opportunities, both in India and Europe.

In our Indian operations, significant efforts are underway to cross key growth milestones in FY27. These target milestones include full utilisation of our newly commissioned Bidkin plant, start of commercial production at our new facilities at Mindewadi near Pune, Shendra, Chennai, G4S Waluj and also expansions in Sanand and ABS facilities."

Result PDF

Non-Electrical Utilities company Indraprastha Gas announced Q3FY26 results

  • Revenue from operations: Rs 4,489.02 crore against Rs 4,142.23 crore during Q3FY25, change 8%.
  • PBT: Rs 503.49 crore against Rs 408.47 crore during Q3FY25, change 23%.
  • PAT: Rs 392.01 crore against Rs 325.42 crore during Q3FY25, change 20%.
  • EPS: Rs 2.81 for Q3FY26.

Result PDF

Trending News

Nestle India adds 20,500 tonnes of Maggi capacity at Sanand facility

Nestle India has announced addition of 20,500 tonnes/annum of Maggi capacity at Sanand facility. 

Published on 02-Apr-2026 09:19

Power Grid wins transmission project for 2.7 GW of renewable energy capacity at Tumkur-II, Karnataka

Power Grid Corporation of India Limited (POWERGRID) has been declared the successful bidder under Tariff-Based Competitive Bidding (TBCB) for a transmission project aimed at integrating 2.7 GW of additional renewable energy capacity at Tumkur-II, Karnataka. 

Published on 02-Apr-2026 09:18

Tata Power resumes operations at 4,150 MW Mundra thermal power plant

Tata Power Company Limited has resumed operations at its 4,150 MW Mundra thermal power plant in Gujarat from April 1, 2026, after a nine-month shutdown. 

Published on 02-Apr-2026 09:17

Indian Bank's gross advances grow 13.6% YoY to ₹6,680 lakh crore

Indian Bank reported steady business growth in Q4FY26 (provisional), with gross advances rising to ₹6.68 lakh crore, up 13.6% YoY (4.5% QoQ). 

Published on 02-Apr-2026 09:16

South Indian Bank's gross advances grow 15.7% YoY to ₹101,295 crore

South Indian Bank reported steady business growth in Q4FY26 (provisional), with gross advances rising to ₹1,01,295 crore, up 15.7% YoY (4.7% QoQ). 

Published on 02-Apr-2026 09:15

Karnataka Bank's gross advances grow 6.9% YoY to ₹83,336.9 crore

Karnataka Bank reported healthy sequential business growth in Q4FY26 (provisional), with gross advances rising to ₹83,336.9 crore, up 6.9% YoY (7.8% QoQ). 

Published on 02-Apr-2026 09:14

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app